LCD ID Number: L37628 Status: A-Approved
LCD Title: In Vitro Chemosensitivity & Chemoresistance Assays
Geographic Jurisdiction: Nevada Other Jurisdictions
Original Determination Effective Date:
10/01/2018
Original Determination Ending Date:
Revision Effective Date:
02/25/2021
Revision End Date:
CMS National Coverage Policy:
Title XVIII of the Social Security Act, §1862(a)(1)(A) allows coverage and payment for only those services that are considered to be reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.
Title XVIII of the Social Security Act, §1862(a)(1)(D) addresses items and service related to research and experimentation.
Title XVIII of the Social Security Act, §1862(a)(7) excludes routine physical examinations.
42 CFR §410.32 Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions
CMS Internet-Only Manual, Pub 100-03, Medicare National Coverage Determinations Manual, Chapter 1, Part 3, §190.7 Human Tumor Stem Cell Drug Sensitivity Assays
CMS Internet-Only Manual, Pub 100-08, Medicare Program Integrity Manual, Chapter 3, §3.2.3.7 Special Provisions for Lab Additional Documentation Requests
Sorry, you need to login or register to view additional sections of this Medicare policy.
*
|